Amkor EVP exercises options, sells 5,000 shares
Amkor Technology executive Mark N. Rogers, EVP & General Counsel, reported exercising 5,000 stock options at $7.40 per share and selling 5,000 common shares at $65.12 on July 16, 2026.
Accepted by SEC EDGAR
Learn about SEC filing dates
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Form Type
4
Rhea-AI Filing Summary
Amkor Technology executive Mark N. Rogers, EVP & General Counsel, reported exercising 5,000 stock options at $7.40 per share and selling 5,000 common shares at $65.12 on July 16, 2026. The sale was effected under a Rule 10b5-1 trading plan adopted on August 1, 2025. After these transactions he directly holds 38,904 common shares and 75,000 stock options from a grant to acquire 200,000 shares that expires on June 10, 2029.
Insider Trade Summary 10b5-1
Exercise and Sale: 5,000 shares ($289K approx. pre-tax spread)
Exercise and Sale
3 txns
Insider
ROGERS MARK N
Role
EVP & General Counsel
Sold
5,000 shs ($326K)
Approx. gross sale proceeds
$326K
Approx. exercise cost
$37K
Approx. pre-tax spread
$289K
Share of Position Sold
11.4%
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Employee Stock Option (Right-to-Buy) F2 | 5,000 | $0.00 | $0.00 |
| Exercise | Common Stock | 5,000 | $7.40 | $37K |
| Sale | Common Stock F1 | 5,000 | $65.12 | $326K |
Holdings After Transaction:
Employee Stock Option (Right-to-Buy) — 75,000 contracts (Direct);
Common Stock — 38,904 shares (Direct)
Holdings Before and After:
Employee Stock Option (Right-to-Buy), 80,000 to 75,000 contracts (Direct);
Common Stock, 38,904 to 38,904 shares (Direct)
Other Insiders: 1 other insider reported open-market sales of this stock in the 30 days up to this filing.
Footnotes (2)
- F1. The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 1, 2025.
- F2. This stock option (the "Option") to acquire 200,000 shares of Amkor Technology, Inc. common stock (the "Option Shares") was granted on June 10, 2019 (the "Option Grant Date") and vested over four years as follows: (i) with respect to 25% of the Option Shares, on the first anniversary of the Option Grant Date; and (ii) with respect to the remainder of the Option Shares, in equal quarterly installments thereafter, such that 100% of the Option vested on the fourth anniversary of the Option Grant Date.
Key Figures
Shares sold: 5,000 shares
Sale price: $65.12 per share
Options exercised: 5,000 shares
+5 more
8 metrics
Shares sold
5,000 shares
Common Stock sale on July 16, 2026 at $65.12 per share
Sale price
$65.12 per share
Price for 5,000 Amkor common shares sold on July 16, 2026
Options exercised
5,000 shares
Common stock acquired via option exercise on July 16, 2026
Option exercise price
$7.40 per share
Exercise price of Employee Stock Option (Right-to-Buy) for 5,000 shares
Shares held after sale
38,904 shares
Direct Amkor common stock holdings by Mark N. Rogers after July 16, 2026 transactions
Options remaining after exercise
75,000 options
Employee Stock Option (Right-to-Buy) position following exercise of 5,000 option shares
Original option grant size
200,000 shares
Shares covered by stock option granted on June 10, 2019
Option expiration date
June 10, 2029
Expiration of Employee Stock Option to acquire Amkor common stock
Key Terms
Rule 10b5-1 trading plan, Employee Stock Option (Right-to-Buy), derivative security, vested
4 terms
Rule 10b5-1 trading plan regulatory
"The sale reported was effected pursuant to a Rule 10b5-1 trading plan"
A Rule 10b5-1 trading plan is a pre-arranged schedule that allows company insiders to buy or sell stock at specific times, even if they have inside information. It helps prevent accusations of unfair trading by making these transactions look planned and transparent, rather than sneaky or illegal.
Employee Stock Option (Right-to-Buy) financial
"Security titled Employee Stock Option (Right-to-Buy) for Amkor common stock"
derivative security financial
"Transaction code M described as Exercise or conversion of derivative security"
A derivative security is a financial contract whose value comes from the price or performance of something else, such as a stock, bond, commodity, or market index. For investors it acts like an insurance policy or a wager: it can be used to protect against losses, lock in prices, or amplify gains and losses, so it can change a portfolio’s risk and potential return without owning the underlying asset directly.
vested financial
"100% of the Option vested on the fourth anniversary of the Option Grant Date"
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What did Amkor (AMKR) executive Mark N. Rogers report on his latest Form 4?
Mark N. Rogers reported exercising 5,000 stock options at $7.40 and selling 5,000 common shares at $65.12 on July 16, 2026. The reported transactions involved Amkor Technology, Inc. common stock and an employee stock option grant originally covering 200,000 shares.
What stock options in Amkor (AMKR) did Mark N. Rogers exercise?
He exercised 5,000 shares under an Employee Stock Option with a $7.40 exercise price on July 16, 2026. That option was part of a grant to acquire 200,000 shares awarded on June 10, 2019, which vests over four years and expires June 10, 2029.
Was Mark N. Rogers’ Amkor (AMKR) stock sale made under a Rule 10b5-1 trading plan?
Yes. The reported sale of 5,000 Amkor shares at $65.12 was effected under a Rule 10b5-1 trading plan. The plan was adopted by Mark N. Rogers on August 1, 2025, providing a pre-arranged framework for executing the sale independently of day-to-day market considerations.
What are the key terms of Mark N. Rogers’ Amkor (AMKR) stock option grant?
The option grant covers 200,000 Amkor common shares, granted on June 10, 2019, vesting over four years. Twenty-five percent vested after one year, with the remainder vesting in equal quarterly installments, and the option is scheduled to expire on June 10, 2029.
AI-generated analysis. How Rhea-AI works. Not financial advice.
